Download PDF
Thromb Haemost 1993; 70(02): 361-369
DOI: 10.1055/s-0038-1649581
Scientific and Standardization Committee Communications
Schattauer GmbH Stuttgart

Antithrombin III Mutation Database: First Update

For the Thrombin and its Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis

Authors

  • D A Lane

    The Charing Cross and Westminster Medical School, London, UK, Institute of Molecular Medicine, Oxford, UK, Thrombosis Research Institute, London, UK, the McMaster University, Hamilton, Canada, University of Cambridge, UK, and Hôpital Broussais, Paris, France

  • R J Olds

    The Charing Cross and Westminster Medical School, London, UK, Institute of Molecular Medicine, Oxford, UK, Thrombosis Research Institute, London, UK, the McMaster University, Hamilton, Canada, University of Cambridge, UK, and Hôpital Broussais, Paris, France

  • M Boisclair

    The Charing Cross and Westminster Medical School, London, UK, Institute of Molecular Medicine, Oxford, UK, Thrombosis Research Institute, London, UK, the McMaster University, Hamilton, Canada, University of Cambridge, UK, and Hôpital Broussais, Paris, France

  • V Chowdhury

    The Charing Cross and Westminster Medical School, London, UK, Institute of Molecular Medicine, Oxford, UK, Thrombosis Research Institute, London, UK, the McMaster University, Hamilton, Canada, University of Cambridge, UK, and Hôpital Broussais, Paris, France

  • S L Thein

    The Charing Cross and Westminster Medical School, London, UK, Institute of Molecular Medicine, Oxford, UK, Thrombosis Research Institute, London, UK, the McMaster University, Hamilton, Canada, University of Cambridge, UK, and Hôpital Broussais, Paris, France

  • D N Cooper

    The Charing Cross and Westminster Medical School, London, UK, Institute of Molecular Medicine, Oxford, UK, Thrombosis Research Institute, London, UK, the McMaster University, Hamilton, Canada, University of Cambridge, UK, and Hôpital Broussais, Paris, France

  • M Blajchman

    The Charing Cross and Westminster Medical School, London, UK, Institute of Molecular Medicine, Oxford, UK, Thrombosis Research Institute, London, UK, the McMaster University, Hamilton, Canada, University of Cambridge, UK, and Hôpital Broussais, Paris, France

  • D Perry

    The Charing Cross and Westminster Medical School, London, UK, Institute of Molecular Medicine, Oxford, UK, Thrombosis Research Institute, London, UK, the McMaster University, Hamilton, Canada, University of Cambridge, UK, and Hôpital Broussais, Paris, France

  • J Emmerich

    The Charing Cross and Westminster Medical School, London, UK, Institute of Molecular Medicine, Oxford, UK, Thrombosis Research Institute, London, UK, the McMaster University, Hamilton, Canada, University of Cambridge, UK, and Hôpital Broussais, Paris, France

  • M Aiach

    The Charing Cross and Westminster Medical School, London, UK, Institute of Molecular Medicine, Oxford, UK, Thrombosis Research Institute, London, UK, the McMaster University, Hamilton, Canada, University of Cambridge, UK, and Hôpital Broussais, Paris, France
Further Information

Publication History

Publication Date:
04 July 2018 (online)

 PDF Download  Permissions and Reprints
Preview Container